Early Detection and Targeted Treatment in an Interdisciplinary Setting

Juvenile idiopathic arthritis is the most common autoimmune disease in childhood—the incidence among children under 16 is approximately 1 in 1,000. Early diagnosis and appropriate treatment remain a challenge. As part of a multidisciplinary approach, collaboration between primary care physicians and specialists in rheumatology—as well as other relevant disciplines when necessary—is crucial for achieving the best possible long-term outcomes. A wide range of disease-modifying medications (csDMARDs, bDMARDs, tsDMARDs) is now available as first-line therapy.